Occult hepatitis B: Prevalence and clinical characteristics in a population with high endemicity of hepatitis B infection in the western Brazilian Amazon region;Hepatite crônica B oculta: Prevalência e aspectos clínicos em população de elevada endemicidade de infecção pelo vírus da hepatite B na Amazônia ocidental brasileira

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 6, 2008, Pages 596-601

  De Barros Jr , Gildo Maia ^a,b,c   Braga, Wornei Silva Miranda ^a,b   De Oliveira, Cintia Mara Costa ^a   Castilho, Márcia Da Costa ^a,b   Araújo, José De Ribamar ^a,b  

^a FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

^b UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^c Gerência de Virologia/FMT AM ^*  (Brazil)

Author keywords

Brazilian Amazon region; Chronic hepatitis; Hepatitis B virus DNA; Occult hepatitis B

Indexed keywords

HEPATITIS B CORE ANTIBODY; VIRUS DNA;

ARTICLE; BLOOD EXAMINATION; BRAZIL; CHEMICAL ANALYSIS; CHRONIC HEPATITIS; DISEASE ASSOCIATION; ENDEMIC DISEASE; HEPATITIS B; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; JAUNDICE; MAJOR CLINICAL STUDY; PARROT; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; SAMPLE SIZE; SENSITIVITY ANALYSIS; VIRUS GENOME;

BRAZIL; DNA, VIRAL; ENDEMIC DISEASES; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

HEPATITIS B VIRUS;

EID: 59349104530     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000600010     Document Type: Article

References (31)

1. Allain JP. Occult hepatitis B virus infection. Transfusion Clinique et Biologique 11:18-25, 2004.
2. Araújo FSB. Diagnóstico da Infecção oculta pelo virus da hepatite B em pacientes com hepatopatia crônica pelo vírus C. Porto Alegre: FFPA. Dissertação de Mestrado, Fundação Faculdade de Ciências Médicas de Porto Alegre, Porto Alegre, RS, 2004.
3. Azevedo RA, Silva AE, Ferraz ML, Marcopolino LF, Baruzzi RG. Prevalência dos marcadores sorológicos dos vírus da hepatite B e D em crianças das tribos Caiabi e Txucarramãe do Parque Indígena do Xingu, Brasil Central. Revistada Sociedade Revista da Sociedade Brasileira de Medicina Tropical 29:431-439, 1996.
4. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289-293, 1996.
5. a edição, Atheneu, São Paulo, p.11-26, 2007.
6. Berasain C, Betés M, Panizo A, Ruiz J, Herrero JI, Civeira MP, Prieto J. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 47:429-435, 2000.
7. Braga WS, Brasil LM, Souza RA, Castilho MC, Fonseca JCF. Ocorrência da infecção pelo vírus da hepatite B (VHB) e delta (VHD) em sete grupos indígenas do Estado do Amazonas. Revista da Sociedade Brasileira de Medicina Tropical 34:349-355, 2001.
8. Braga WS, Silva EB, Souza RA, Tosta CE. Soroprevalência da infecção pelo vírus da hepatite B e pelo plasmódio em Lábrea, Amazonas: estimativa da ocorrência de prováveis coinfecções. Revista da Sociedade Brasileira de Medicina Tropical 38:218-223, 2005.
9. Brasil LM, Braga WS, Fonseca JCF, Souza RA. Fatores de risco na transmissão do vírus da hepatite C (HCV) na Amazônia Ocidental. Revista da Sociedade Brasileira de Medicina Tropical 31 (supl I):87, 1998.
10. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?. Hepatology 34:194-203, 2001.
11. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. New England Journal of Medicine 341:22-26, 1999.
12. Center Disease Central. Epi Info™ statistical software, version 3.3.2, CDC; Atlanta GA, 2005.
13. Chan HL, Tsang SW, Leung NW, Tse CH, Hui Y, Tan JS, Chan FK, Sung JJ. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. American Journal of Gastroenterology 97:1211-1215, 2002.
14. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay L, Cova L, Chevallier P, Mandrand B, Trépo C. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. Journal of Hepatology 34:447-454, 2001.
15. Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology 34:204-206, 2001.
16. Gayotto LCC. Biópsia hepática. In: Gayotto LCC (ed) Doenças do Fígado e Vias Biliares. Editora Atheneu, São Paulo, p.151-163, 2001.
17. Lee WM. Hepatitis B virus infection. New England Journal of Medicine 337:1733-1745, 1997.
18. Luo KX, Zhou R, He C, Liang ZS, Jiang SB. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. Journal of Medical Virology 35:55-59, 1991.
19. Medrano FJ, Sánchez-Quijano A, Pineda J, Lissen E. Isolated anti-HBc and hepatitis B virus occult infection. Vox Sanguinis 61:140, 1991.
20. Minuk GY, Sun DF, Uhanova J, Zhang M, Caouette S, Nicolle LE, Gutkin A, Doucette K, Martin B, Giulivi A. "Occult hepatitis B virus infection in a North American community-based population". Journal of Hepatology 42:480-485, 2005.
21. Nalpas B, Pourcel C, Feldmann G, Housset G, Tiollais P, Brechot C, Berthelot P, Farza H. Chronic alcohol intoxication decreases the serum level of hepatitis B surface antigen in transgenic mice. Journal of Hepatology 15:118-124, 1992.
22. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21:313-321, 1995.
23. Piliero PJ, Faragon JJ. Case report. Hepatitis B virus and HIV coinfection. AIDS Read 12:443-444, 2002.
24. Raimondo G. Occult hepatitis B virus infection and liver disease: fact or fiction?. Journal of Hepatology 34:473, 2001.
25. a edição, Guanabara Koogan, Rio de Janeiro, p.277-288, 2004.
26. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, Wands J, Sninsky J, Tiollais P. Transmission of hepatitis B seronegative subjects. Lancet 2:1273-1276, 1988.
27. Torbenson M, Thomas DL. Occult hepatitis B. The Lancet infectious Diseases 2:479-486, 2002.
28. Weber B, Muhlbacher A, Melchior W. Detection of an acute asymptomatic HBSAg negative hepatitis B virus infection in a blood donor by HBV DNA testing. Journal of Clinical Virology 32:67-70, 2005.
29. Weinberger KM, Bauer T, Bohm S, Jilg W. High genetic variability of the group specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. The Journal of General Virology 81:1165-1174, 2000.
30. Zhang YY, Hansson BG, Kuo LS, Widell A, Nordenfelt E. Hepatitis B virus DNA in Serum and Liver Is Commonly Found in Chinese Patients with Chronic Liver Disease Despite the Presence of Antibodies to HBsAg. Hepatology 17:538-544, 1993.
31. Zuckerman JN, Zuckerman AJ. Mutations of the surface protein of B virus. Antiviral Research 60:75-78, 2003.